Overview
Joseph Baxter practices practicing medicine in London, United Kingdom.
His clinical expertise encompasses Adult Soft Tissue Sarcoma, Rhabdomyosarcoma, and Breast Cancer.
He is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Joseph S. Baxter
Is Joseph S. Baxter a top-rated expert for Adult Soft Tissue Sarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Joseph S. Baxter is classified as an Experienced expert for Adult Soft Tissue Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Joseph S. Baxter participate in research or clinical trials?
Yes. Joseph S. Baxter has published 10 articles and abstracts on conditions like Adult Soft Tissue Sarcoma. You can view a list of Joseph S. Baxter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adult Soft Tissue SarcomaMr. Baxter isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Breast CancerMr. Baxter isExperienced. Learn about Breast Cancer.
- RhabdomyosarcomaMr. Baxter isExperienced. Learn about Rhabdomyosarcoma.